The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Open accessPublished version of a preprint
Abstract
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The S protein mediates binding of coronaviruses to angiotensin converting enzyme 2 (ACE2) on the surface of various cell types including epithelial cells of the pulmonary alveolus (4–6).”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“it directly interacts with the cellular receptor angiotensin converting enzyme 2 (ACE2) which mediates host cell entry”
From SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (2021) · cites this paper as Letko et al., 2020
In the citing paper
“SARS-CoV-2 is a single-stranded RNA β-coronavirus and a member of the subgenus Sarbecovirus (beta-CoV lineage B).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
In the citing paper
“It is the seventh member of the Coronaviridae known to infect humans so far, two of which, SARS-CoV and MERS-CoV, caused global health threats previously (Guarner, 2020; Letko et al., 2020).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Tsoi, H., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K., & Yuen, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,561
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,076
Cited by
Sorted by citations
Items 901–1,000 of 1,005
Mohammadi, S., Heidarizadeh, M., Entesari, M., Esmailpour, A., Esmailpour, M., Moradi, R., Sakhaee, N., & Doustkhah, E. (2020) · Microorganisms · doi:10.3390/microorganisms8101600 · Cited by 36
Namazova-Baranova, L. S., & Aa, B. (2020) · PULMONOLOGIYA · doi:10.18093/0869-0189-2020-30-5-609-628 · Cited by 42
Hou, Y., Ge, S., Li, X., Wang, C., He, H., & He, L. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109420 · Cited by 36
Oristrell, J., Oliva, J. C., Subirana, I., Casado, E., Domínguez, D., Toloba, A., Aguilera, P., Clos, J. E., Fafián, P., & Grau, M. (2021) · Biomedicines · doi:10.3390/biomedicines9050509 · Cited by 34
Zhang, J., Huang, F., Xia, B., Yuan, Y., Yu, F., Wang, G., Chen, Q., Wang, Q., Li, Y., Li, R., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00604-5 · Cited by 36
Huang, C., Tan, Z., Zhao, K., Zou, W., Wang, H., Gao, H., Sun, S., Bu, D., Chai, W., & Li, Y. (2021) · iScience · doi:10.1016/j.isci.2021.103272 · Cited by 38
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Prates-Syed, W. A., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A. A. D. L., Côrtes, N., Kersten, V., Guimarães, F. E. G., Sadraeian, M., da Silva, F. L. B., et al. (2021) · Vaccines · doi:10.3390/vaccines9121409 · Cited by 36
Ying, B., Scheaffer, S. M., Whitener, B. M., Liang, C.-Y., Dmytrenko, O., Mackin, S., Wu, K., Lee, D. W., Avena, L. E., Chong, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.07.479419 · Cited by 35
Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19
Li, J., Xu, G., Yu, H., Peng, X., Luo, Y., & Cao, C. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.040 · Cited by 34
Arbidol: The current demand, strategies, and antiviral mechanisms
Kang, Y., Shi, Y., & Xu, S. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.984 · Cited by 34
Host range, transmissibility and antigenicity of a pangolin coronavirus
Hou, Y. J., Chiba, S., Leist, S. R., Meganck, R. M., Martinez, D. R., Schäfer, A., Catanzaro, N., Sontake, V., West, A., Edwards, C. E., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01476-x · Cited by 36
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Lee, J., Zepeda, S. K., Park, Y., Taylor, A. L., Quispe, J. D., Stewart, C., Leaf, E. M., Treichel, C., Corti, D., King, N. P., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.10.018 · Cited by 33
ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2
Fam, B. S. D. O., Vargas‐Pinilla, P., Amorim, C. E. G., Sortica, V. A., & Bortolini, M. C. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0104 · Cited by 34
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
Neogi, U., Hill, K. J., Ambikan, A. T., Heng, X., Quinn, T. P., Byrareddy, S. N., Sönnerborg, A. B., Sarafianos, S. G., & Singh, K. (2020) · Pathogens · doi:10.3390/pathogens9050320 · Cited by 34
Lisco, G., Tullio, A. D., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine · doi:10.1007/s12020-020-02444-9 · Cited by 37
Might SARS‐CoV‐2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?
Sirotkin, K. M., & Sirotkin, D. (2020) · BioEssays · doi:10.1002/bies.202000091 · Cited by 34
Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
Yadav, M., Dhagat, S., & Eswari, S. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105522 · Cited by 34
Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
Jena, N. R. (2021) · Chemical Physics Impact · doi:10.1016/j.chphi.2021.100011 · Cited by 34
Lai, H. I. A. M., Chou, S., Chien, Y., Tsai, P., Chien, C., Hsu, C., Jheng, Y.-C., Wang, M., Chiou, S., Chou, Y.-B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031320 · Cited by 34
Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (S)-P-Phosphoramidation
Gannedi, V., Villuri, B. K., Reddy, S. N., Ku, C., Wong, C., & Hung, S. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c02888 · Cited by 34
Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
Shukla, N., Roelle, S. M., Suzart, V. G., Bruchez, A. M., & Matreyek, K. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009715 · Cited by 33
Munster, V. J., Flagg, M., Singh, M., Yinda, C. K., Williamson, B. N., Feldmann, F., Pérez-Pérez, L., Schulz, J. E., Brumbaugh, B., Holbrook, M. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj3627 · Cited by 34
Self-citationA Bidirectional Long Short-Term Memory Model Algorithm for Predicting COVID-19 in Gulf Countries
Aldhyani, T. H. H., & Alkahtani, H. S. (2021) · Life · doi:10.3390/life11111118 · Cited by 34
Jiang, W., Shi, L., Cai, L., Wang, X., Li, J., Li, H., Liang, J., Gu, Q., Ji, G., Li, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110112 · Cited by 33
Johnson, S., Martinez, C. I., Tedjakusuma, S. N., Peinovich, N., Dora, E. G., Birch, S. M., Kajon, A. E., Werts, A. D., & Tucker, S. N. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab561 · Cited by 34
Point-of-Care Testing—The Key in the Battle against SARS-CoV-2 Pandemic
Iliescu, F. S., Ionescu, A. M., Gogianu, L., Simion, M., Dediu, V., Chifiriuc, M. C., Pîrcălăbioru, G. G., & Iliescu, C. (2021) · Micromachines · doi:10.3390/mi12121464 · Cited by 37
Łaźniewski, M., Dermawan, D., Hidayat, S., Muchtaridi, M., Dawson, W., & Plewczyński, D. (2022) · Methods · doi:10.1016/j.ymeth.2022.02.004 · Cited by 37
Osman, I. O., Garrec, C., de Souza, G. A. P., Zarubica, A., Belhaouari, D. B., Baudoin, J., Lépidi, H., Mège, J., MALISSEN, B., Scola, B. L., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.798767 · Cited by 34
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Saha, T., Quiñones-Mateu, M., & Das, S. C. (2022) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2022.122042 · Cited by 36
Al-Qahtani, A. A., Pantazi, I., Alhamlan, F. S., Alothaid, H., Matou‐Nasri, S., Sourvinos, G., Vergadi, E., & Tsatsanis, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020624 · Cited by 37
Zhang, Q., Wang, M., Han, C., Wen, Z., Meng, X., Qi, D., Wang, N., Du, H., Wang, J., Lu, L., et al. (2023) · Vaccines · doi:10.3390/vaccines11030673 · Cited by 35
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
Goyal, R., Gautam, R. K., Chopra, H., Dubey, A. K., Singla, R. K., Rayan, R. Α., & Kamal, M. A. (2022) · EXCLI journal · doi:10.17179/excli2022-5355 · Cited by 38
de Lima, L. F., Ferreira, A. L., Ranjan, I., Collman, R. G., de Araujo, W. R., & de la Fuente‐Núñez, C. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101476 · Cited by 33
Iorio‐Morin, C., Hodaie, M., Sarica, C., Dea, N., Westwick, H. J., Christie, S., McDonald, P. J., Labidi, M., Farmer, J., Brisebois, S., et al. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa157 · Cited by 33
Díaz, L. A., García‐Salum, T., Fuentes–López, E., Marcela Ferrés, G., Medina, R., & Riquelme, A. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.014 · Cited by 33
Features of enteric disease from human coronaviruses: Implications for COVID‐19
Cimolai, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26066 · Cited by 32
Ai, J., Zi, H., Wang, Y., Huang, Q., Wang, N., Li, L.-Y., Pei, B., Ji, J., & Zeng, X. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00308 · Cited by 33
Wang, H., Song, J., Yao, Y., Deng, Y., Wang, Z., Liao, B., Ma, J., He, C., Li, P., Yang, L., et al. (2020) · Allergy · doi:10.1111/all.14569 · Cited by 32
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
Fadaka, A. O., Sibuyi, N. R. S., Adewale, O. B., Bakare, O. O., Akanbi, M. O., Klein, A., Madiehe, A. M., & Meyer, M. (2020) · Journal of International Medical Research · doi:10.1177/0300060520949077 · Cited by 33
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
Wu, C., Lin, Y., Yang, Y., Shu, L., Cheng, Y., & Liu, H. T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110816 · Cited by 34
Istıflı, E. S., Netz, P. A., Tepe, A. S., Hüsunet, M. T., Sarıkürkçü, C., & Tepe, B. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1840444 · Cited by 33
Fagre, A. C., Manhard, J., Adams, R., Eckley, M., Zhan, S., Lewis, J., Rocha, S. M., Woods, C., Kuo, K., Liao, W., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614256 · Cited by 33
COVID-DeepPredictor: Recurrent Neural Network to Predict SARS-CoV-2 and Other Pathogenic Viruses
Saha, I., Ghosh, N., Maity, D., Seal, A., & Plewczyński, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.569120 · Cited by 33
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
Cárdenas‐Rodríguez, N., Bandala, C., Vanoye–Carlo, A., Ignacio‐Mejía, I., Gómez‐Manzo, S., Cruz, E. Y. H., Pedraza‐Chaverrí, J., Carmona‐Aparicio, L., & Hernández‐Ochoa, B. (2021) · Antioxidants · doi:10.3390/antiox10060971 · Cited by 34
Ghidoli, M., Colombo, F., Sangiorgio, S., Landoni, M., Giupponi, L., Nielsen, E., & Pilu, R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.661331 · Cited by 36
Possible mechanisms of cholesterol elevation aggravating COVID-19
Tang, Y., Hu, L., Liu, Y., Zhou, B., Qin, X., Ye, J., Shen, M., Wu, Z., & Zhang, P. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62021 · Cited by 33
Single domain shark VNAR antibodies neutralize SARS‐CoV‐2 infection in vitro
Gauhar, A., Privezentzev, C. V., Demydchuk, M., Gerlza, T., Rieger, J., Kungl, A. J., Walsh, F. S., Rutkowski, J. L., & Stocki, P. (2021) · The FASEB Journal · doi:10.1096/fj.202100986rr · Cited by 30
Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells
Constantino, F. B., Cury, S. S., Nogueira, C. R., Carvalho, R. F., & Justulin, L. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.614728 · Cited by 33
Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii
Kiefer, A. M., Niemeyer, J., Probst, A., Erkel, G., & Schroda, M. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.988870 · Cited by 37
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
He, W., Yuan, M., Callaghan, S., Musharrafieh, R. G., Song, G., Silva, M., Beutler, N., Lee, W.-H., Yong, P., Torres, J. L., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl9605 · Cited by 32
Taha, B. A., Mashhadany, Y. I. M. A., Al-Jubouri, Q., Haider, A. J., Chaudhary, V., Apsari, R., & Arsad, N. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105187 · Cited by 33
Veljković, V., Vergara‐Alert, J., Segalés, J., & Paessler, S. (2020) · F1000Research · doi:10.12688/f1000research.22149.4 · Cited by 38
An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
Khan, M. Z. I., Nazli, A., Al-furas, H., Asad, M. I., Ajmal, I., Khan, D., Shah, J., Farooq, M. A., & Jiang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1034444 · Cited by 37
Tirelli, C., AMICI, M. D., Albrici, C., Mira, S., Nalesso, G., Re, B., Corsico, A. G., Mondoni, M., & Centanni, S. (2023) · Biology · doi:10.3390/biology12020177 · Cited by 35
Halfmann, P., Loeffler, K., Duffy, A., Kuroda, M., Yang, J. E., Wright, E., Kawaoka, Y., & Kane, R. S. (2024) · Nature Communications · doi:10.1038/s41467-024-45495-6 · Cited by 31
An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare
Витальевич, Г. Д., Khantimirova, L. M., Шевцов, В. А., Рукавишников, А. В., Меркулов, В. А., & Olefir, Y. V. (2020) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2020-20-1-6-20 · Cited by 32
Therapeutic Options for COVID-19: A Review
Pujari, R. R., Thommana, M. V., Mercedes, B. R., & Serwat, A. (2020) · Cureus · doi:10.7759/cureus.10480 · Cited by 33
Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses
Cimolai, N. (2020) · Health Security · doi:10.1089/hs.2020.0067 · Cited by 33
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
Adem, K. A., Shanti, A., Stefanini, C., & Lee, S. (2020) · Pharmaceuticals · doi:10.3390/ph13120447 · Cited by 33
Soni, S., Jiang, Y., Tesfaigzi, Y., Hornick, J. L., & Çataltepe, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247510 · Cited by 33
Pandamooz, S., Jurek, B., Meinung, C.-P., Baharvand, Z., Shahem-abadi, A. S., Haerteis, S., Miyan, J. A., Downing, J. R., Dianatpour, M., Borhani‐Haghighi, A., et al. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-121120-012309 · Cited by 31
Issa, H., Eid, A. H., Berry, B., Takhviji, V., Khosravi, A., Mantash, S., Nehme, R., Hallal, R., Karaki, H., Dhayni, K., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.620990 · Cited by 30
Reconstruction of Ultra‐thin Alveolar‐capillary Basement Membrane Mimics
Jain, P., Nishiguchi, A., Linz, G., Weßling, M., Ludwig, A., Rossaint, R., Möller, M., & Singh, S. (2021) · Advanced Biology · doi:10.1002/adbi.202000427 · Cited by 32
Larsen, S. E., Berube, B. J., Pecor, T., Cross, E., Brown, B. P., Williams, B. D., Johnson, E., Qu, P., Carter, L. P., Wrenn, S. P., et al. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113160 · Cited by 32
Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2
Cecon, E., Izabelle, C., Poder, S. L., Real, F., Zhu, A., Tu, L., Ghigna, M., Klonjkowski, B., Bomsel, M., Jockers, R., et al. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12772 · Cited by 33
In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2
Mulgaonkar, N., Wang, H., Mallawarachchi, S., Růžek, D., Martina, B. E. E., & Fernando, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2045221 · Cited by 34
MacLean, O. A., Lytras, S., Weaver, S., Singer, J. B., Boni, M. F., Lemey, P., Pond, S. L. K., & Robertson, D. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.122366 · Cited by 33
Kuzmina, A., Wattad, S., Khalaila, Y., Ottolenghi, A., Rosental, B., Engel, S., Rosenberg, E., & Taube, R. (2021) · iScience · doi:10.1016/j.isci.2021.103467 · Cited by 33
Management of Atrial Fibrillation in COVID-19 Pandemic
Hu, Y., Cheng, W., Hung, Y., Lin, W., Chao, T., Liao, J., Lin, Y., Lin, W., Chen, Y., & Chen, S. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0566 · Cited by 30
Roshandel, R., Nateqi, M., Lak, R., Aavani, P., Motlagh, R. S., Badr, T. A., Sfakianos, J. P., Kaplan, S. A., Shariat, S. F., & Tewari, A. K. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.6.26 · Cited by 32
Zhou, J., Wu, B., Wang, W., Lei, F., Cheng, X., Qin, J., Cai, J., Zhang, X., Zhou, F., Liu, Y.-M., et al. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i22.5576 · Cited by 30
Xu, K., Wei, Y., Giunta, S., Zhou, M., & Xia, S. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111423 · Cited by 31
Liver injury in COVID-19: Detection, pathogenesis, and treatment
Cai, Y., Ye, L., Song, Y.-Q., Mao, X., Wang, L., Jiang, Y., Que, W., & Li, S.-W. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.3022 · Cited by 30
Sharifi, Y., Payab, M., Mohammadi‐Vajari, E., Aghili, S. M. M., Sharifi, F., Mehrdad, N., Kashani, E., Shadman, Z., Larijani, B. A., & Ebrahimpur, M. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00822-2 · Cited by 32
Current treatment strategies for COVID‑19 (Review)
Han, F., Liu, Y., Mo, M., Chen, J., Wang, C., Yang, Y., & Wu, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12498 · Cited by 34
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
Yuan, Y., Zhang, X., Chen, R., Li, Y., Wu, B., Li, R., Zou, F., Ma, X., Wang, X., Chen, Q., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110256 · Cited by 31
Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
Nakamura, T., Isoda, N., Sakoda, Y., & Harashima, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.046 · Cited by 32
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Hauser, B. M., Sangesland, M., Denis, K. S., Lam, E. C., Case, J. B., Windsor, I. W., Feldman, J. E., Caradonna, T. M., Kannegieter, T., Diamond, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110561 · Cited by 38
COVID-19 Pandemic and Osteoporosis in Elderly Patients
Tang, J. (2022) · Aging and Disease · doi:10.14336/ad.2021.1201 · Cited by 34
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications
Prabhakar, P. K., Khurana, N., Vyas, M., Sharma, V., Batiha, G. E., Kaur, H., Singh, J., Kumar, D., Sharma, N., Kaushik, A. K., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020451 · Cited by 32
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisPreprint
Stevens, C. S., Oguntuyo, K. Y., Kowdle, S., Brambilla, L., Haas, G. D., Gowlikar, A., Siddiquey, M. N. A., Schilke, R. M., Woolard, M. D., Zhang, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.14.248880 · Cited by 33
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidatesPreprint
Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., Villemagne, D., Paladino, M., Hospodarsch, T., Neculcea, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.256339 · Cited by 30
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationPreprint
Gallagher, K., Leick, M. B., Larson, R. C., Berger, T. R., Katsis, K., Yam, J. Y., Brini, G., Grauwet, K., MGH COVID-19 Collection & Processing Team, & Maus, M. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.03.442455 · Cited by 32
Can N95 respirators be reused after disinfection? And for how many times?
Liao, L., Xiao, W., Zhao, M., Yu, X., Wang, H., Wang, Q., Chu, S., & Cui, Y. (2020) · doi:10.1101/2020.04.01.20050443 · Cited by 433
“It was found that the SARS-CoV-2 utilizes the ACE2 more efficiently than SARS-CoV, which may explain why the human-to-human transmissibility of the virus is so high 6, 7 .”
MethodDYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
Strine, M. S., Cai, W. L., Wei, J., Alfajaro, M. M., Filler, R. B., Biering, S. B., Sarnik, S. A., Chow, R. D.-W., Patil, A., Cervantes, K. S., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002097 · Cited by 29
Zhao, X., Qiu, T., Huang, X., Mao, Q., Wang, Y., Qiao, R., Li, J., Mao, T., Wang, Y., Cun, Y., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00648-1 · Cited by 30
Song, G., Yuan, M., Liu, H., Capozzola, T., Lin, R. N., Torres, J. L., He, W., Musharrafieh, R., Dueker, K., Zhou, P.-P., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115948 · Cited by 30
Prezioso, C., Marcocci, M. E., Palamara, A. T., Chiara, G. D., & Pietropaolo, V. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00862-z · Cited by 30
Emerging Prevention and Treatment Strategies to Control COVID-19
Singh, V. K., Mishra, A., Singh, S., Kumar, P., Singh, M., Jagannath, C., & Khan, A. (2020) · Pathogens · doi:10.3390/pathogens9060501 · Cited by 31
The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19
Wang, D., Huang, J., Yeung, A. W. K., Tzvetkov, N. T., Horbańczuk, J. O., Willschke, H., Gai, Z., & Atanasov, A. G. (2020) · Processes · doi:10.3390/pr8080937 · Cited by 29
Animal coronaviruses in the light of COVID-19
Domańska-Blicharz, K., Woźniakowski, G., Konopka, B., Niemczuk, K., Welz, M., Rola, J., Socha, W., Orłowska, A., Antas, M., Śmietanka, K., et al. (2020) · Journal of Veterinary Research · doi:10.2478/jvetres-2020-0050 · Cited by 31
Riordan, P., Stika, M. M., Goldberg, J., & Drzewiecki, M. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1810325 · Cited by 34
SARS-CoV-2: Zoonotic origin of pandemic coronavirus
Vilček, Š. (2020) · Acta Virologica · doi:10.4149/av_2020_302 · Cited by 29
The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
de Carvalho, P. R., Sirois, P., & Fernandes, P. D. (2020) · Peptides · doi:10.1016/j.peptides.2020.170428 · Cited by 32
Susceptibility of livestock and companion animals to COVID‐19
Sreenivasan, C. C., Thomas, M., Wang, D., & Li, F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26621 · Cited by 31
Murillo, J., Villegas-Trujillo, L. M., Ulloa-Murillo, L. M., & Rodríguez, A. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104162 · Cited by 31
Ghodake, G. S., Shinde, S. K., Kadam, A. A., Saratale, R. G., Saratale, G. D., Syed, A., Elgorban, A. M., Marraiki, N., & Kim, D.-Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.112969 · Cited by 31
Ramazzotti, D., Angaroni, F., Maspero, D., Gambacorti-Passerini, C. B., Antoniotti, M., Graudenzi, A., & Piazza, R. (2021) · Patterns · doi:10.1016/j.patter.2021.100212 · Cited by 29
Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Konstantinidis, T. G., Voidarou, C. C., Κωνσταντινίδης, Θ. Κ., & Bezirtzoglou, E. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.619075 · Cited by 30
Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
Abbasi, A. Z., Kiyani, D. A., Hamid, S. M., Saalim, M., Fahim, A., & Jalal, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26911 · Cited by 29
Metadata
- Authors
- Letko, M., Marzi, A., & Munster, V.
- Affiliations
- National Institutes of Health (US)
- National Institute of Allergy and Infectious Diseases (US)
- Corresponding author
- Letko, Michael
- Munster, Vincent
- Venue
- Nature Microbiology
- Published
- 2020-02-24
- Volume
- 5
- Issue
- 4
- Pages
- 562-569
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7095430
- OpenAlex
- W3008394341
- Cited by
- 3,109
- References
- 38
- Citations by year
- 2026: 47 · 2025: 122 · 2024: 198 · 2023: 287 · 2022: 571 · 2021: 874 · 2020: 1002
- FWCI
- 89.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Chinese Center for Disease Control and Prevention
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Keywords
- SARS-CoV-2, SARS-CoV, cell entry, ACE2 receptor, zoonotic transmission, viral recombination, cross-species infection
- MeSH terms
- Protein Domains, Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Cell Line, Humans, Peptidyl-Dipeptidase A, Mutation, Pneumonia, Viral, Receptors, Virus, Recombinant Fusion Proteins, Trypsin, Coronavirus Infections, Dipeptidyl Peptidase 4, CD13 Antigens, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
